- All Articles
- Biologics Zone
- Blood Management
- ECMO Zone
- Education Zone
- i-Pump Quick Reference
- Main Zone
- Mobile Zone
- Multimedia Zone
- Pediatric Zone
- Perfusion Devices
- Perfusion Zone
- Premium Zone
- Warnings and Recalls
Mitral Valve Surgery: Current Minimally Invasive and Transcatheter Options
In this article, we review current techniques for minimally invasive cardiac surgery (MICS) for mitral valve repair or replacement (MVR/r) and upcoming catheter-based therapies for the mitral valve.
Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery
We performed a patient-level combined analysis of randomized, controlled trials to compare radial-artery grafts and saphenous-vein grafts for coronary-artery bypass grafting (CABG).
Emergent Cardiac Surgery During Transcatheter Aortic Valve Implantation (TAVI): A Weighted Meta-Analysis of 9,251 Patients From 46 Studies
Refinement in transcatheter aortic valve implantation (TAVI) technology should not only focus on miniaturisation and improving flexibility of the delivery systems and/or devices -which may have the potential for decreasing aortic dissection, annular rupture, and tamponade- but also incorporate modifications to prevent embolisation/dislocation of the valve.
The Dutch Hospital Standardized Mortality Ratio (HSMR) Method and Cardiac Surgery: Benchmarking in a National Cohort Using Hospital Administration Data Versus a Clinical Database
The objective of this study is to compare the accuracy of data from hospital administration databases and a national clinical cardiac surgery database and to compare the performance of the Dutch hospital standardised mortality ratio (HSMR) method and the logistic European System for Cardiac Operative Risk Evaluation, for the purpose of benchmarking of mortality across hospitals.
Goal-Directed Therapy in Cardiac Surgery: A Systematic Review and Meta-Analysis
There is evidence that perioperative goal-directed haemodynamic therapy (GDT) may reduce surgical mortality and morbidity in non-cardiac surgical patients, the data are less clear after cardiac surgery. The objective of this review is to perform a meta-analysis on the effects of perioperative GDT on mortality, morbidity, and length of hospital stay in cardiac surgical patients.
Transcatheter Aortic Valve Implantation (TAVI) by Centers with and without an On-Site Cardiac Surgery Program: Preliminary Experience from the German TAVI Registry
This study analysed patient characteristics, decision-making processes, and outcomes of TAVI performed in hospitals with versus those without on-site cardiac surgery (CS).
Comparison of Immediate Extubation Versus Ultrafast Tracking Strategy in the Management of Off-Pump Coronary Artery Bypass Surgery
Ultrafast tracking of anesthesia (UFTA) is practiced routinely, whereas immediate on-table extubation after off-pump coronary artery bypass (OPCAB) grafting surgery has many concerns. The purpose of our study was to evaluate the safety and feasibility of immediate extubation (IE) versus UFTA.
The Feasibility and Safety of Off-Pump Coronary Bypass Surgery in Emergency Revascularization
The efficacy and safety of off-pump coronary artery bypass grafting (OPCAB) in emergency revascularization remains controversial despite its widespread use. The aim of our study was to examine the applicability and safety of OPCAB in patients who were indicated for emergency surgery.
Off-Pump Coronary Artery Bypass Grafting with Mini-Sternotomy in the Treatment of Triple-Vessel Coronary Artery Disease
We have developed off-pump coronary artery bypass approach with lower distal mini-sternotomy (TM-OPCAB) for multivessel coronary revascularization. The aim of this retrospective study is to provide evidence for the feasibility and safety of this technique in the treatment of triple-vessel diseases.
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve
We hypothesized that fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) would be superior to medical therapy as initial treatment in patients with stable coronary artery disease.
Hybrid Extracorporeal Membrane Oxygenation
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) therapy is widely used in critically ill patients with refractory cardiogenic shock and cardiac arrest or suffering from severe respiratory failure. Besides traditional ECMO cannulation, changes in patients’ conditions or the occurrence of specific complications (i.e., cerebral hypoxia or left ventricular dilation) may require modifications in cannulation strategies or the combination of ECMO with additional invasive or minimally invasive procedures, to improve organ function and ECMO efficiency.
Early LVAD Implantation in a Patient with Left Ventricular Failure after Aortic Dissection with Left Main Stem Involvement
Coronary involvement in aortic dissection heralds a poor outcome. Involvement of the left main stem may lead to left ventricular (LV) failure requiring mechanical circulatory support.
Implementation of a Mechanical CPR Device in a Physician Staffed HEMS – A Prospective Observational Study
In this prospective, observational study we describe the incidence and characteristics of out of hospital cardiac arrest (OHCA) cases who received mechanical CPR, after the implementation of a mechanical CPR device.
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?
The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings.
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement
We compared long-term mortality and rates of reoperation, stroke, and bleeding between inverse-probability-weighted cohorts of patients who underwent primary aortic-valve replacement or mitral-valve replacement with a mechanical or biologic prosthesis in California in the period from 1996 through 2013.